Showing results (71-80 of 117) with videos related to
Sort By:
Pageof 12
American Journal of Physiology. Renal Physiology|June 28, 2021
Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney diseaseMette V Østergaard, Thomas Secher, Michael Christensen, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|August 7, 2012
Improving membrane binding as a design strategy for amphipathic peptide hormones: 2-helix variants of PYY3-36Søren L Pedersen, Vikram K Bhatia, Simon Jurt, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2020
Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db miceMette Simone Aae Madsen, Rikke Veggerby Grønlund, John Eid, et al.Scientific Reports|February 2, 2022
Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effectFlora Alexopoulou, Esben Matzen Bech, Søren Ljungberg Pedersen, et al.Molecular Metabolism|July 14, 2017
The endogenous preproglucagon system is not essential for gut growth homeostasis in micePernille Wismann, Pernille Barkholt, Thomas Secher, et al.Scientific Reports|January 26, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisHelene M Ægidius, Sanne S Veidal, Michael Feigh, et al.Journal of Molecular Endocrinology|June 3, 2008
Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenomeKjersti M Aagaard-Tillery, Kevin Grove, Jacalyn Bishop, et al.Journal of Medicinal Chemistry|August 4, 2017
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) AnaloguesEsben M Bech, Manuel C Martos-Maldonado, Pernille Wismann, et al.Scientific Reports|November 1, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceMette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, et al.The Journal of Endocrinology|May 29, 2010
Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndromeAndreas Nygaard Madsen, Gitte Hansen, Sarah Juel Paulsen, et al.Pageof 12